Variant report
Variant | esv3441359 |
---|---|
Chromosome Location | chr7:147585772-147592059 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543759324 | chr7:147585778-147585779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2538976 | chr7:147585819-147585820 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs2708253 | chr7:147585865-147585866 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs546911702 | chr7:147585873-147585874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10608123 | chr7:147585904-147585905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs398067388 | chr7:147585907-147585908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566797919 | chr7:147585914-147585915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144209439 | chr7:147586022-147586023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552178208 | chr7:147586036-147586037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78584397 | chr7:147586042-147586043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57921419 | chr7:147586093-147586094 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs992368 | chr7:147586119-147586120 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs76229836 | chr7:147586138-147586139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553357017 | chr7:147586178-147586179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10488350 | chr7:147586182-147586183 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs577504324 | chr7:147586227-147586228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531610424 | chr7:147586303-147586304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs180681055 | chr7:147586359-147586360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35357395 | chr7:147586396-147586397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34580784 | chr7:147586397-147586398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13235491 | chr7:147586438-147586439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116956878 | chr7:147586439-147586440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576561912 | chr7:147586455-147586456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146538105 | chr7:147586465-147586466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs13235505 | chr7:147586468-147586469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2538975 | chr7:147586474-147586475 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs186291050 | chr7:147586494-147586495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373430633 | chr7:147586518-147586519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546805915 | chr7:147586553-147586554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2215798 | chr7:147586581-147586582 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs532458314 | chr7:147586592-147586593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551854209 | chr7:147586599-147586600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34002554 | chr7:147586600-147586601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568844599 | chr7:147586652-147586653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575231800 | chr7:147586700-147586701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192143787 | chr7:147586755-147586756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547879320 | chr7:147586780-147586781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11977877 | chr7:147586818-147586819 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs371957189 | chr7:147586838-147586839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534113232 | chr7:147586850-147586851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554374763 | chr7:147586881-147586882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571019601 | chr7:147586889-147586890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17170737 | chr7:147586930-147586931 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs375085996 | chr7:147586932-147586933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556235692 | chr7:147586957-147586958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551630398 | chr7:147586979-147586980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6958734 | chr7:147587002-147587003 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs555881389 | chr7:147587009-147587010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150842897 | chr7:147587139-147587140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs75449030 | chr7:147587140-147587141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Heart disease | 21282601 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Lobular carcinoma | 20920651 | CNVD |
Long-qt syndrome | 20920651 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:147582000-147589400 | Weak transcription | Brain Substantia Nigra | brain |
2 | chr7:147589400-147592000 | Enhancers | Brain Substantia Nigra | brain |
3 | chr7:147589600-147591600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr7:147590400-147590600 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr7:147590400-147591400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr7:147590600-147591600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr7:147590600-147591800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr7:147590600-147591800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr7:147590600-147592000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr7:147590800-147591600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr7:147590800-147591600 | Enhancers | Brain Anterior Caudate | brain |
12 | chr7:147590800-147591600 | Enhancers | Brain Cingulate Gyrus | brain |
13 | chr7:147590800-147591600 | Enhancers | Brain Inferior Temporal Lobe | brain |
14 | chr7:147590800-147591800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr7:147591000-147591600 | Enhancers | Brain Angular Gyrus | brain |
16 | chr7:147591000-147591800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
17 | chr7:147591000-147591800 | Enhancers | Brain Hippocampus Middle | brain |
18 | chr7:147591000-147592000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr7:147591200-147591800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
20 | chr7:147591400-147591800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr7:147591600-147593400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
22 | chr7:147591800-147593600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
23 | chr7:147592000-147592800 | Weak transcription | H1 Cell Line | embryonic stem cell |